Abstract
In the present study, the ability of suramin 18 mg/kg i.p. twice a week to induce chronic neurotoxicity in rats was investigated. After 20 weeks of suramin treatment, morphological analysis of nerve fibers demonstrated that 57.7±3.2% of them presented vesicular disruption of myelin sheaths; their thickness was 0.23±0.07 μm in suramin-treated rats with respect to 0.43±0.07 μm of controls ( P<0.05). To investigate the interaction between suramin and nerve tissue, the binding of the drug to partially purified myelin P 0 protein obtained from sciatic nerves was analysed. The percentage of suramin bound to rat myelin P 0 protein was 94.0±9.5%; this value was decreased to 55.0±7.6% when heparan sulfate was added to the myelin protein suspension before suramin. The analysis of tissue drug concentrations at 5, 10 and 20 weeks of treatment showed that suramin accumulated into the sciatic nerve in a time-dependent fashion (130.8±18.1, 219.7±17.1 and 449.3±15.6 μg/g of tissue, respectively). In conclusion, suramin induces a chronic peripheral neurotoxicity in rats characterized by myelin damage and high tissue levels of the drug. The high affinity of suramin for partially purified myelin P 0 protein suggests a possible mechanism for drug-induced toxicity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
